Good news as pharmaceutical giant GSK announce €12m investment for Cork manufacturing plant
Multinational pharmaceutical giant GSK has announced a new €12m investment at its manufacturing plant outside Cork city in Currabinny. The announcement includes a new manufacturing facility and laboratory that will underpin future investment at its Currabinny site in Cork.
The new purpose-built Kilo Scale Facility will allow the site to begin manufacturing highly specialised active ingredients for newer, targeted oncology medicines while the new Technical Development Laboratory will further enhance its ability to improve its current product portfolio which includes treatments for diseases such as cancer, HIV and depression.
“Our new Kilo Scale Facility represents an important new opportunity for GSK in Cork, the plant will expand our operating scale to allow us introduce new targeted medicines that require highly specialised manufacturing equipment, this investment opens up new potential for Cork to produce these in the future,”
Keving O’Keefe, Head of Engineering GSK Cork
GSK are a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare.
With world-class manufacturing sites in Cork, Dungarvan and Sligo, they research, develop, manufacture and make available a broad range of innovative healthcare products – from prescription medicines and vaccines, to well-known brands like Panadol, Aquafresh and NiQuitin.GSK, Investment, jobs in cork